Diagnostic tests: Human immunodeficiency virus type 1, type 2 (HIV-1, HIV 2)
Fujii, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 7): 434-437
2005
ISSN/ISBN: 0047-1852 PMID: 16111295 Document Number: 586156
Document emailed within 1 workday
Related Documents
Machado, A.A.; Hirsch, I.; Figueiredo, J.F.; Martinez, R.; de Freitas-Silva, G.; Chermann, J.C.; Covas, D.T. 1996: Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1) Revista da Sociedade Brasileira de Medicina Tropical 29(6): 615-617Balzarini, J.; Velazquez, S.; San-Felix, A.; Karlsson, A.; Perez-Perez, M.J.; Camarasa, M.J.; De Clercq, E. 1993: Human immunodeficiency virus type 1-specific [2',5'-bis-O-(tert- butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"- oxathiole-2",2"-dioxide)-purine analogues show a resistance spectrum that is different from that of the human immunodeficiency virus type 1-specific non-nucleoside analogues Molecular Pharmacology 43(1): 109-114
Nagot, N.; Ouedraogo, A.; Konate, I.; Weiss, H.A.; Foulongne, V.; Defer, M.C.; Sanon, A.; Becquart, P.; Segondy, M.; Sawadogo, A.; Van de Perre, P.; Mayaud, P.; Bahembera, E.; Berthe, A.; Coulibaly, M.; Defer, M.-C.; Diallo, R.; Djagbare, D.; Konate, I.; Ky-Dama, F.; M'Boutiki, G.T.; Meda, N.; Millogo, I.; Ouedraogo, A.; Ouedraogo, D.; Rouet, F.ço.; Sanon, A.; Sawadogo, H.; Vallo, R.; Andonaba, J.-B.; Sawadogo, A.; Mayaud, P.; Weiss, H.A.; Nagot, N.; Becquart, P.; Foulongne, V.; Segondy, M.; Van de Perre, P. 2008: Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels Journal of Infectious Diseases 198(2): 241-249
Okuku, H.Selassie.; Sanders, E.J.; Nyiro, J.; Ngetsa, C.; Ohuma, E.; McClelland, R.Scott.; Price, M.A.; Graham, S.M. 2011: Factors associated with herpes simplex virus type 2 incidence in a cohort of human immunodeficiency virus type 1-seronegative Kenyan men and women reporting high-risk sexual behavior Sexually Transmitted Diseases 38(9): 837-844
Yusim, K.; Peeters, M.; Pybus, O.G.; Bhattacharya, T.; Delaporte, E.; Mulanga, C.; Muldoon, M.; Theiler, J.; Korber, B. 2001: Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 356(1410): 855-866
Yoshida, M. 2005: Diagnostic tests: Herpes simplex virus type 1 and 2 Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 7): 291-293
Hirose, G. 2005: Diagnostic tests: Anti-neuronal nuclear antibodies, type 1 and type 2 Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 7): 476-478
Berntorp, E.; Jarevi, G.; Vedback, A.; Nilsson, I.M. 1986: Living adenovirus type 4 vaccine human t lymphotropic virus type iii antibodies in swedish hemophiliacs in relation to type and dosage of factor concentrate Thrombosis Research (Suppl 6): 18
Mmbaga, E.J.; Leyna, G.H.; Stray-Pedersen, B.; Klepp, K.-I. 2011: Herpes simplex virus type-2 and human immunodeficiency virus infections in a rural population in Kilimanjaro Tanzania East African Journal of Public Health 8(1): 28-32
Devare, S.G.; Desai, S.M.; Rupprecht, K.R.; Allen, R.G.; Dawson, G.J.; Hunt, J.C.; Casey, J.M. 1988: Genes of human immunodeficiency virus, type i (HIV-I), their expression in Escherichia coli, and their utility in diagnosis of virus infection Indian Journal of Biochemistry and Biophysics 25(6): 504-509
Scott-Wright, A.; Hakre, S.; Bryan, J.P.; Jaramillo, R.; Reyes, L.G.; Cruess, D.; Macarthy, P.O.; Gaydos, J.C. 1997: Hepatitis B virus, human immunodeficiency virus type-1, and syphilis among women attending prenatal clinics in Belize, Central America American Journal of Tropical Medicine and Hygiene 56(3): 285-290
Mahiane, S.G.; Ndong Nguema, E.P.; Pretorius, C.; Auvert, B. 2010: Mathematical models for coinfection by two sexually transmitted agents: the human immunodeficiency virus and herpes simplex virus type 2 case Applied Statistics 59(4): 547-572
Krieger, J.N.; Nirapathpongporn, A.; Chaiyaporn, M.; Peterson, G.; Nikolaeva, I.; Akridge, R.; Ross, S.O.; Coombs, R.W. 1998: Vasectomy and human immunodeficiency virus type 1 in semen Journal of Urology 159(3): 820
Vzorov, A.N.; Dixon, D.W.; Trommel, J.S.; Marzilli, L.G.; Compans, R.W. 2002: Inactivation of human immunodeficiency virus type 1 by porphyrins Antimicrobial Agents and Chemotherapy 46(12): 3917-3925
Lawson, V.A.; Oelrichs, R.; Guillon, C.; Imrie, A.A.; Cooper, D.A.; Deacon, N.J.; McPhee, D.A. 2002: Adaptive changes after human immunodeficiency virus type 1 transmission Aids Research and Human Retroviruses 18(8): 545-556
Almaghrabi, R.S.; Ali, B.; Al-Thawadi, S.; Halim, M.A.; Alrajhi, A.A. 2011: Human immunodeficiency virus type 2 in two Saudi families Annals of Saudi Medicine 31(4): 417-420
Selimova, L.M.; Kalnina, L.B.; Serebrovskaya, L.V.; Ivanova, L.A.; Gulyaeva, A.N.; Nosik, D.N. 2016: Cytokines during the Human Immunodeficiency Virus Infection type 1(Hiv-1) Voprosy Virusologii 61(1): 39-41
Caputo, A.; Grossi, M.P.; Rossi, C.; Campioni, D.; Balboni, P.G.; Corallini, A.; Barbanti-Brodano, G. 1995: The tat gene and protein of the human immunodeficiency virus type 1 New Microbiologica 18(1): 87-110
Begovac, J.; Babić, K.; Soldo, I.; Maretić, T. 1988: The human immunodeficiency virus type i and the nervous system Lijecnicki Vjesnik 110(9-10): 332-338
Horsburgh, C.R.; Holmberg, S.D. 1988: The global distribution of human immunodeficiency virus type 2 (HIV-2) infection Transfusion 28(2): 192-195